212 related articles for article (PubMed ID: 24359616)
1. CHD1L: a novel oncogene.
Cheng W; Su Y; Xu F
Mol Cancer; 2013 Dec; 12(1):170. PubMed ID: 24359616
[TBL] [Abstract][Full Text] [Related]
2. Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival.
Chen L; Hu L; Chan TH; Tsao GS; Xie D; Huo KK; Fu L; Ma S; Zheng BJ; Guan XY
Hepatology; 2009 Jul; 50(1):122-9. PubMed ID: 19441106
[TBL] [Abstract][Full Text] [Related]
3. CHD1L promotes tumor progression and predicts survival in colorectal carcinoma.
Ji X; Li J; Zhu L; Cai J; Zhang J; Qu Y; Zhang H; Liu B; Zhao R; Zhu Z
J Surg Res; 2013 Nov; 185(1):84-91. PubMed ID: 23746766
[TBL] [Abstract][Full Text] [Related]
4. CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma.
Li S; Chai Y; Ding Y; Yuan T; Wu C; Huang C
Oncol Rep; 2019 Aug; 42(2):657-669. PubMed ID: 31173252
[TBL] [Abstract][Full Text] [Related]
5. Chromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast Cancer.
Mu QJ; Li HL; Yao Y; Liu SC; Yin CG; Ma XZ
PLoS One; 2015; 10(11):e0143030. PubMed ID: 26599012
[TBL] [Abstract][Full Text] [Related]
6. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
[TBL] [Abstract][Full Text] [Related]
7. CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.
Chen L; Chan TH; Yuan YF; Hu L; Huang J; Ma S; Wang J; Dong SS; Tang KH; Xie D; Li Y; Guan XY
J Clin Invest; 2010 Apr; 120(4):1178-91. PubMed ID: 20335658
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of chromodomain helicase DNA binding protein 1-like protein in human solid cancers: A meta-analysis.
Liu W; Xu J; Zhang C
Medicine (Baltimore); 2018 Jul; 97(29):e11522. PubMed ID: 30024537
[TBL] [Abstract][Full Text] [Related]
9. The high expression of CHD1L and its clinical significance in human solid tumors: A meta-analysis.
Zhang L; Jiang Y; Jiao P; Deng X; Xie Y
Medicine (Baltimore); 2021 Mar; 100(10):e24851. PubMed ID: 33725840
[TBL] [Abstract][Full Text] [Related]
10. CHD1L Regulates Cell Cycle, Apoptosis, and Migration in Glioma.
Sun J; Zhang L; Zhao H; Qiu X; Chen W; Wang D; Ban N; Fan S; Shen C; Xia X; Ji B; Wang Y
Cell Mol Neurobiol; 2016 May; 36(4):565-76. PubMed ID: 26162969
[TBL] [Abstract][Full Text] [Related]
11. CHD1L promotes EOC cell invasiveness and metastasis via the regulation of METAP2.
He WP; Guo YY; Yang GP; Lai HL; Sun TT; Zhang ZW; Ouyang LL; Zheng Y; Tian LM; Li XH; You ZS; Xie D; Yang GF
Int J Med Sci; 2020; 17(15):2387-2395. PubMed ID: 32922205
[TBL] [Abstract][Full Text] [Related]
12. CHD1L prevents lipopolysaccharide-induced hepatocellular carcinomar cell death by activating hnRNP A2/B1-nmMYLK axis.
Wang G; Zhang X; Cheng W; Mo Y; Chen J; Cao Z; Chen X; Cui H; Liu S; Huang L; Liu M; Ma L; Ma NF
Cell Death Dis; 2021 Sep; 12(10):891. PubMed ID: 34588420
[TBL] [Abstract][Full Text] [Related]
13. Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development.
Chan TH; Chen L; Liu M; Hu L; Zheng BJ; Poon VK; Huang P; Yuan YF; Huang JD; Yang J; Tsao GS; Guan XY
Hepatology; 2012 Feb; 55(2):491-505. PubMed ID: 21953552
[TBL] [Abstract][Full Text] [Related]
14. CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer.
Liu C; Fu X; Zhong Z; Zhang J; Mou H; Wu Q; Sheng T; Huang B; Zou Y
Dig Dis Sci; 2017 Sep; 62(9):2376-2385. PubMed ID: 28646284
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.
He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D
Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781
[TBL] [Abstract][Full Text] [Related]
16. Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancer.
Wu J; Zong Y; Fei X; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
PLoS One; 2014; 9(8):e98673. PubMed ID: 25153161
[TBL] [Abstract][Full Text] [Related]
17. CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer.
Li Y; He LR; Gao Y; Zhou NN; Liu Y; Zhou XK; Liu JF; Guan XY; Ma NF; Xie D
Cell Death Dis; 2019 Feb; 10(2):99. PubMed ID: 30718500
[TBL] [Abstract][Full Text] [Related]
18. CHD1L protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival.
He WP; Zhou J; Cai MY; Xiao XS; Liao YJ; Kung HF; Guan XY; Xie D; Yang GF
BMC Cancer; 2012 Sep; 12():437. PubMed ID: 23020525
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion.
Chen L; Yuan YF; Li Y; Chan TH; Zheng BJ; Huang J; Guan XY
Gut; 2011 Apr; 60(4):534-43. PubMed ID: 21068133
[TBL] [Abstract][Full Text] [Related]
20. Expression of CHD1L in bladder cancer and its influence on prognosis and survival.
Tian F; Xu F; Zhang ZY; Ge JP; Wei ZF; Xu XF; Cheng W
Tumour Biol; 2013 Dec; 34(6):3687-90. PubMed ID: 23807680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]